Greetings from Morepen Laboratories Limited, India.

Morepen Laboratories Limited as one of the preferred APIs Intermediates manufacturers in the global pharma market for Innovator Generic companies worldwide including highly regulated markets like US, Canada, Japan Western Europe.

Morepen is supported by a 40 members RD team, which has 24 published process and polymorph patents to its credit for Loratadine, Desloratadine, Montelukast, Atorvastatin, Fexofenadine, etc. We invest in RD and offer the product to our customers for licensing/contract manufacturing with required regulatory documents like

Drug Master File both Open and Close parts (COS/ EDMFs)

Method Process Validations

Non-Infringement patent statement.

Morepen Laboratories Limited is the world s largest manufacturer of Loratadine, an antihistaminic drug, which is manufactured at our USFDA approved facility in Parwanoo, Himachal Pradesh. Our USFDA approved plant coupled with excellent documentation and customer service is our winning edge.

Additionally, we have Montelukast, which is a key molecule for us and we have four process patents for this molecule in the regulated market. This product is also backed by the complete regulatory documentary requirement.

The APIs which are commercially available are as below :

Montelukast Sodium ( EDMF )

Loratadine ( USDMF, CEP)

Desloratadine ( USDMF, EDMF )

Atorvastatin Calcium Amorphous ( USDMF, EDMF )

Atorvastatin Calcium Crystalline ( USDMF, EDMF )

Fexofenadine Hydrochloride ( EDMF )

Rosuvastatin Calcium ( Tech Pack )

Aliskiren Hemifumerate

Prasugrel

Valsartan

Voglibose